TMB USA

At TaiMed Biologics, we are more than just a company; we are a beacon of hope and innovation in the fight against HIV. Our unwavering commitment to excellence, combined with our relentless pursuit of groundbreaking, breakthrough therapies, is reshaping the HIV treatment paradigm. As we continue to advance our mission, we remain dedicated to improving the lives of patients and contributing significantly to the field of biopharmaceutical innovation... Building on the success of Trogarzo®, TaiMed is persistently pioneering the evolution and development of a revolutionary long-acting monoclonal antibody (mAb)-based combination therapy using emerging novel technology platforms. Our goal is to establish this therapy as the leading choice for first-line maintenance therapy in HIV. Our vision is to become a globally recognized, highly specialized company in HIV drug development, addressing the critical and unmet medical needs of patients worldwide.

Also known as: TaiMed Biologics, TMB USA Inc.

Primary location: Hsinchu Taiwan (r.o.c.)